	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	56.23	59.76	103.57	109.15	105.61	106.64	231.81
Cost of Operating Revenue	43.85	48.10	83.04	81.31	79.26	77.98	180.09
Gross Profit	12.38	11.66	20.53	27.83	26.35	28.65	51.72
Gross Margin	22.0	19.5	19.8	25.5	25.0	26.9	22.3
Total Operating Expenses	54.07	57.32	98.92	99.53	96.16	97.92	210.12
Operating Profit	2.16	2.44	4.65	9.62	9.44	8.71	21.69
Operating Margin	3.8	4.1	4.5	8.8	8.9	8.2	9.4
Financing Income/(Expense) - Net	-1.49	-1.65	-2.84	0.06	1.51	-1.47	-3.97
Profit before Taxes	0.85	1.52	3.40	10.06	12.78	10.47	23.59
Income Taxes	0.35	0.38	0.68	2.42	2.98	2.42	5.40
Profit after Tax	0.50	1.15	2.72	7.64	9.80	8.04	18.19
PAT Margin	0.9	1.9	2.6	7.0	9.3	7.5	7.8
EPS - Basic - ex Extraordinary Items	0.48	1.10	2.60	7.32	9.85	7.70	15.39
EPS - Diluted - ex Extraordinary Items	0.48	1.10	2.60	7.32	9.85	7.70	14.94
EBIT	2.16	2.44	4.65	9.62	9.44	8.71	21.69
EBITDA	2.66	3.07	5.99	10.47	10.47	10.14	23.22
EBITDA Margin	4.7	5.1	5.8	9.6	9.9	9.5	10.0

Balance Sheet

Abridged

Understanding Balance Sheet

Hemant Surgical Industries Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	PR	AR	AR	AR	AR	PRESS
Total Current Assets	28.75	25.57	37.65	46.71	69.30	88.80	192.42
Long-Term Investments	1.18	1.18	0.82	0.36	4.93	1.25	-
Property Plant & Equipment - Net	10.15	11.90	10.07	13.15	17.66	51.81	53.45
Total Non-Current Assets	15.56	17.32	15.66	17.98	27.34	59.51	81.84
Total Assets	44.30	42.90	53.31	64.69	96.64	148.31	274.26
Total Current Liabilities	29.39	22.70	36.55	37.66	37.79	61.26	133.09
Long Term Debt	7.50	10.32	4.64	3.06	3.54	23.33	2.88
Total Non-Current Liabilities	7.70	10.59	4.90	3.67	3.99	23.88	3.52
Total Liabilities	37.08	33.28	41.45	41.34	41.78	85.14	136.62
Total Shareholders' Equity	7.22	9.61	11.86	23.36	54.86	63.17	137.64
Total Equity	7.22	9.61	11.86	23.36	54.86	63.17	137.64
Total Liabilities & Equity	44.30	42.90	53.31	64.69	96.64	148.31	274.26

Cash Flow

Abridged

Understanding Cash Flow Statement

Hemant Surgical Industries Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	0.04	1.79	4.06	9.88	10.58	10.95	19.81
Working Capital - Increase/(Decrease)	0.13	-3.71	8.11	-5.29	-17.96	-3.67	-54.15
Net CF from Operating Activities	0.17	-1.92	12.17	4.59	-7.38	7.28	-34.34
Capital Expenditures - Net	2.71	2.39	0.42	3.93	5.52	35.33	2.13
Net CF from Investing Activities	-1.93	-2.49	1.21	-3.47	-10.09	-30.87	-4.64
Stock - Issuance/(Retirement) - Net	-	-	-	2.80	21.70	-	54.52
Debt - LT & ST - Issuance/(Retirement) - Total	3.15	0.63	-6.43	-1.28	0.48	19.79	18.76
Net Cash Flow from Financing Activities	3.99	2.32	-7.67	1.52	22.18	19.79	73.27
Free Cash Flow to Equity	0.60	-3.68	5.32	-0.63	-12.42	-8.26	-17.72
Free Operating CF net dividend	-2.55	-4.31	11.74	0.66	-12.90	-30.29	-36.47
Free Operating CF	-2.55	-4.31	11.74	0.66	-12.90	-30.29	-36.47

Business Segment Analysis

Hemant Surgical Industries Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Hemant Surgical Industries Ltd.

Regional Segment Analysis

Hemant Surgical Industries Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Hemant Surgical Industries Ltd.

Historical Segment Analysis

Track how Hemant Surgical Industries Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Hemant Surgical Industries Ltd.

Frequently Asked Questions

What is the revenue of Hemant Surgical Industries Ltd.?

The latest trailing twelve month revenue of Hemant Surgical Industries Ltd. is ₹ 231.81 Cr, reflecting a 1-year growth of 117.38% and a 3-year CAGR of 28.54%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Hemant Surgical Industries Ltd.?

The latest trailing twelve month net profit (PAT) of Hemant Surgical Industries Ltd. is ₹ 18.19 Cr, with a 3-year earnings CAGR of 26.87%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Hemant Surgical Industries Ltd.?

The trailing twelve month EBITDA of Hemant Surgical Industries Ltd. is approximately ₹ 21.69 Cr (based on an operating margin of 9.36%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Hemant Surgical Industries Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Hemant Surgical Industries Ltd. is 14.94. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Hemant Surgical Industries Ltd.?

The debt-to-equity ratio of Hemant Surgical Industries Ltd. stands at 0.36. The interest coverage ratio is 5.47x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Hemant Surgical Industries Ltd.?

The estimated book value per share of Hemant Surgical Industries Ltd. is 94.68 (derived from a P/B ratio of 4.11 and market price of ₹ 389.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Hemant Surgical Industries Ltd.?

The trailing twelve month operating cash flow of Hemant Surgical Industries Ltd. is ₹ -34.34 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Hemant Surgical Industries Ltd. report consolidated or standalone financials?

Hemant Surgical Industries Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.